Clinical-Radiomics Signature Predicts Pathologic Complete Response After Neoadjuvant Therapy in Oesophageal Squamous Cell Carcinoma
Interdisciplinary CardioVascular and Thoracic Surgery · 05.02.2026 · 41 (2)
DOI: 10.1093/icvts/ivag024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Interdisciplinary CardioVascular and Thoracic Surgery, online erschienen am 04.02.2026. Verfasst von Liqiang Shi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Esophageal Neoplasms, Radiomics, Esophageal Squamous Cell Carcinoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Interdisciplinary Program of Shanghai Jiao Tong University.
Abstract (Originalsprache)
Objectives
Neoadjuvant therapy (NAT) significantly improves the pathologic complete response (pCR) rates in patients with locally advanced esophageal squamous cell carcinoma (ESCC). Emerging evidence suggests that patients with pCR may experience favourable outcomes and could be considered for active surveillance strategies to delay surgery. This study aims to develop a clinical-radiomics model to predict pCR after NAT in ESCC.
Methods
We retrospectively enrolled 236 patients with locally advanced ESCC who received NAT at our centre and randomly assigned them to training and test cohorts (3:2 ratio). Radiomics features were extracted from tumour regions segmented on post-NAT contrast-enhanced computed tomography (CT) scans. After feature selection, a predictive model integrating radiomics and clinical variables was developed using logistic regression and visualized as a nomogram. Model performance was evaluated using area under the curve (AUC), accuracy, sensitivity, and specificity.
Results
The clinical-radiomics model achieved an AUC of 0.91 (95% confidence interval [CI]: 0.86-0.95), accuracy of 0.84, sensitivity of 0.89, and specificity of 0.81 in the training cohort, and an AUC of 0.84 (95% CI: 0.76-0.92), accuracy of 0.78, sensitivity of 0.84, and specificity of 0.74 in the test cohort. Calibration curves demonstrated good agreement between predicted and observed outcomes, and decision curve analysis confirmed the model’s clinical utility.
Conclusions
The clinical-radiomics model accurately predicts pCR following NAT in ESCC and may guide personalized treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
- Department of Nuclear Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
- Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
- Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
ORCID-Profile: Yuqin Cao, Hecheng Li
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Interdisciplinary Program of Shanghai Jiao Tong University
- Novel Interdisciplinary Research Project from Shanghai Municipal Health Commission
- Clinical Research Project in Health Services of Shanghai Municipal Health Commission
- Shanghai Leading Talent Program from Shanghai Municipal Commission of Commerce
Zitieren
APA
Shi, L., Wang, X., Chen, X., Cao, Y., Li, C., Bai, Y., Cheng, Z., Dong, D., Chen, X., Zhang, Y., & Li, H. (2026). Clinical-Radiomics Signature Predicts Pathologic Complete Response After Neoadjuvant Therapy in Oesophageal Squamous Cell Carcinoma. Interdisciplinary CardioVascular and Thoracic Surgery, 41(2). https://doi.org/10.1093/icvts/ivag024
Vancouver
Shi L, Wang X, Chen X, Cao Y, Li C, Bai Y, et al. Clinical-Radiomics Signature Predicts Pathologic Complete Response After Neoadjuvant Therapy in Oesophageal Squamous Cell Carcinoma. Interdisciplinary CardioVascular and Thoracic Surgery. 2026;41(2). doi:10.1093/icvts/ivag024
BibTeX
@article{Shi2026,
author = {Shi, Liqiang and Wang, Xipeng and Chen, Xueyu and Cao, Yuqin and Li, Chengqiang and Bai, Yaya and Cheng, Zenghui and Dong, Dong and Chen, Xiaoyan and Zhang, Yajie and Li, Hecheng},
title = {Clinical-Radiomics Signature Predicts Pathologic Complete Response After Neoadjuvant Therapy in Oesophageal Squamous Cell Carcinoma},
journal = {Interdisciplinary CardioVascular and Thoracic Surgery},
year = {2026},
volume = {41},
number = {2},
doi = {10.1093/icvts/ivag024}
}
EUVIMED